Search Results - "Gaebler, Christian"
-
1
Plasma Neutralization of the SARS-CoV-2 Omicron Variant
Published in The New England journal of medicine (10-02-2022)“…Neutralization assays of SARS-CoV-2 pseudoviruses expressing wild-type, omicron, or a synthetic resistant spike protein in plasma drawn from 47 people over…”
Get full text
Journal Article -
2
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Published in The Journal of experimental medicine (02-11-2020)“…The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease has generated a need for assays to rapidly and conveniently measure the…”
Get full text
Journal Article -
3
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Published in Nature (London) (16-12-2021)“…The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in individuals who are SARS-CoV-2 convalescent and vaccinated are key…”
Get full text
Journal Article -
4
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Published in Nature (London) (15-07-2021)“…More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text
Journal Article -
5
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Published in Cell (20-08-2020)“…Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal…”
Get full text
Journal Article -
6
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Published in Nature communications (07-07-2021)“…Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions…”
Get full text
Journal Article -
7
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Published in Science translational medicine (20-01-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), primarily infects cells at mucosal…”
Get more information
Journal Article -
8
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Published in eLife (28-10-2020)“…Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against…”
Get full text
Journal Article -
9
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Published in Nature (London) (07-07-2022)“…The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals 1 – 3 . Despite the reduced protection from infection, individuals who…”
Get full text
Journal Article -
10
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Published in Nature (London) (16-12-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time,…”
Get full text
Journal Article -
11
Persistent cellular immunity to SARS-CoV-2 infection
Published in The Journal of experimental medicine (05-04-2021)“…SARS-CoV-2 is responsible for an ongoing pandemic that has affected millions of individuals around the globe. To gain further understanding of the immune…”
Get full text
Journal Article -
12
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Published in Immunity (Cambridge, Mass.) (10-08-2021)“…Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent…”
Get full text
Journal Article -
13
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination
Published in Nature (London) (26-01-2023)“…Feedback inhibition of humoral immunity by antibodies was first documented in 1909 1 . Subsequent studies showed that, depending on the context, antibodies can…”
Get full text
Journal Article -
14
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
Published in Cell (28-03-2013)“…Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs…”
Get full text
Journal Article -
15
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Published in Nature (London) (06-12-2012)“…Passive immunotherapy with a combination of neutralizing monoclonal antibodies is shown to be effective in suppressing HIV replication in a humanized mouse…”
Get full text
Journal Article -
16
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Published in Nature communications (09-08-2021)“…Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database…”
Get full text
Journal Article -
17
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
Published in Nature communications (19-01-2023)“…Waves of SARS-CoV-2 infection have resulted from the emergence of viral variants with neutralizing antibody resistance mutations. Simultaneously, repeated…”
Get full text
Journal Article -
18
Impact of misclassified defective proviruses on HIV reservoir measurements
Published in Nature communications (13-07-2023)“…Most proviruses persisting in people living with HIV (PWH) on antiretroviral therapy (ART) are defective. However, rarer intact proviruses almost always…”
Get full text
Journal Article -
19
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
Published in The Journal of experimental medicine (05-12-2022)“…Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough…”
Get full text
Journal Article -
20
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells
Published in Nature communications (19-08-2022)“…Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by CD8 + cytotoxic T-cells. Clinical studies of latency reversing…”
Get full text
Journal Article